Your browser doesn't support javascript.
loading
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis.
Moreno-Castaño, Ana Belen; Fernández, Sara; Ventosa, Helena; Palomo, Marta; Martinez-Sanchez, Julia; Ramos, Alex; Ortiz-Maldonado, Valentín; Delgado, Julio; Fernández de Larrea, Carlos; Urbano-Ispizua, Alvaro; Penack, Olaf; Nicolás, J M; Téllez, Adrian; Escolar, Gines; Carreras, Enric; Fernández-Avilés, Francesc; Castro, Pedro; Diaz-Ricart, Maribel.
Afiliação
  • Moreno-Castaño AB; Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain abmoreno@clinic.cat.
  • Fernández S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain.
  • Ventosa H; Intensive Care Unit, Clinical Institute of Medicine and Dermatology (ICMID), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Palomo M; Intensive Care Unit, Clinical Institute of Medicine and Dermatology (ICMID), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Martinez-Sanchez J; Hematology External Quality Assessment Laboratory, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
  • Ramos A; Institut de Recerca Contra la Leucèmia Josep Carreras, Campus Clínic, Barcelona, Spain.
  • Ortiz-Maldonado V; Institut de Recerca Contra la Leucèmia Josep Carreras, Campus Clínic, Barcelona, Spain.
  • Delgado J; Hematology Department, Clinical Institute of Hematologic and Oncologic Diseases (ICMHO), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Fernández de Larrea C; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain.
  • Urbano-Ispizua A; Hematology Department, Clinical Institute of Hematologic and Oncologic Diseases (ICMHO), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Penack O; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain.
  • Nicolás JM; Hematology Department, Clinical Institute of Hematologic and Oncologic Diseases (ICMHO), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Téllez A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain.
  • Escolar G; Hematology Department, Clinical Institute of Hematologic and Oncologic Diseases (ICMHO), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Carreras E; Hematology Department, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Fernández-Avilés F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain.
  • Castro P; Intensive Care Unit, Clinical Institute of Medicine and Dermatology (ICMID), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Diaz-Ricart M; Intensive Care Unit, Clinical Institute of Medicine and Dermatology (ICMID), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
J Immunother Cancer ; 11(4)2023 04.
Article em En | MEDLINE | ID: mdl-37045474
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemostáticos / Sepse / Neoplasias Hematológicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemostáticos / Sepse / Neoplasias Hematológicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article